Celldex Therapeutics, Inc. (CLDX)
39.42
+0.18
(+0.46%)
USD |
NASDAQ |
Sep 02, 10:41
Celldex Therapeutics 1 Year Total Returns (Daily) : 77.72% for Sept. 1, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 01, 2026 | 77.72% |
| August 31, 2026 | 79.48% |
| August 28, 2026 | 74.80% |
| August 27, 2026 | 79.03% |
| August 26, 2026 | 86.53% |
| August 25, 2026 | 87.96% |
| August 24, 2026 | 80.63% |
| August 21, 2026 | 83.38% |
| August 20, 2026 | 91.19% |
| August 19, 2026 | 73.61% |
| August 18, 2026 | 70.71% |
| August 17, 2026 | 64.39% |
| August 14, 2026 | 68.20% |
| August 13, 2026 | 70.51% |
| August 12, 2026 | 88.53% |
| August 11, 2026 | 121.5% |
| August 10, 2026 | 108.0% |
| August 07, 2026 | 96.65% |
| August 06, 2026 | 93.84% |
| August 05, 2026 | 85.54% |
| August 04, 2026 | 79.13% |
| August 03, 2026 | 69.85% |
| July 31, 2026 | 73.16% |
| July 30, 2026 | 68.72% |
| July 29, 2026 | 70.89% |
| Date | Value |
|---|---|
| July 28, 2026 | 61.65% |
| July 27, 2026 | 52.68% |
| July 24, 2026 | 51.94% |
| July 23, 2026 | 48.39% |
| July 22, 2026 | 55.50% |
| July 21, 2026 | 61.65% |
| July 20, 2026 | 58.05% |
| July 17, 2026 | 53.90% |
| July 16, 2026 | 54.05% |
| July 15, 2026 | 67.66% |
| July 14, 2026 | 63.40% |
| July 13, 2026 | 68.18% |
| July 10, 2026 | 72.44% |
| July 09, 2026 | 73.55% |
| July 08, 2026 | 82.65% |
| July 07, 2026 | 90.32% |
| July 06, 2026 | 72.50% |
| July 02, 2026 | 73.54% |
| July 01, 2026 | 73.41% |
| June 30, 2026 | 82.85% |
| June 29, 2026 | 84.52% |
| June 26, 2026 | 66.56% |
| June 25, 2026 | 58.85% |
| June 24, 2026 | 56.03% |
| June 23, 2026 | 61.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 36.17% |
| Ionis Pharmaceuticals, Inc. | 40.45% |
| ACADIA Pharmaceuticals, Inc. | 11.16% |
| Alnylam Pharmaceuticals, Inc. | -44.88% |
| Anika Therapeutics, Inc. | 125.1% |